SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'R4L'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UWJ_A_BAXA1723_2 (B-RAF PROTO-ONCOGENESERINE/THREONINE-PROTEIN KINASE) |
4b99 | MITOGEN-ACTIVATEDPROTEIN KINASE 7 (Homosapiens) | 5 / 7 | ILE A 61LYS A 84LEU A 106ILE A 114ASP A 200 | R4L A1394 (-4.0A)NoneNoneNoneNone | 0.76A | 1uwjA-4b99A:5.5 | 1uwjA-4b99A:24.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YI4_A_ADNA306_1 (PROTO-ONCOGENESERINE/THREONINE-PROTEIN KINASE PIM-1) |
4b99 | MITOGEN-ACTIVATEDPROTEIN KINASE 7 (Homosapiens) | 5 / 10 | ALA A 82ILE A 115LEU A 137ASP A 143LEU A 189 | R4L A1394 ( 3.7A)R4L A1394 (-4.9A)R4L A1394 (-3.9A)R4L A1394 ( 4.2A)R4L A1394 (-4.5A) | 0.88A | 1yi4A-4b99A:22.7 | 1yi4A-4b99A:24.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2XP2_A_VGHA9000_1 (TYROSINE-PROTEINKINASE RECEPTOR) |
4b99 | MITOGEN-ACTIVATEDPROTEIN KINASE 7 (Homosapiens) | 7 / 9 | VAL A 69ALA A 82LEU A 137MET A 140LEU A 189GLY A 199ASP A 200 | R4L A1394 (-4.0A)R4L A1394 ( 3.7A)R4L A1394 (-3.9A)NoneR4L A1394 (-4.5A)R4L A1394 ( 4.1A)None | 0.76A | 2xp2A-4b99A:6.5 | 2xp2A-4b99A:23.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Y7J_A_B49A1294_1 (PHOSPHORYLASE BKINASE GAMMACATALYTIC CHAIN,TESTIS/LIVER ISOFORM) |
4b99 | MITOGEN-ACTIVATEDPROTEIN KINASE 7 (Homosapiens) | 7 / 12 | ILE A 61VAL A 69ALA A 82ILE A 115LEU A 139MET A 140LEU A 189 | R4L A1394 (-4.0A)R4L A1394 (-4.0A)R4L A1394 ( 3.7A)R4L A1394 (-4.9A)R4L A1394 ( 4.9A)NoneR4L A1394 (-4.5A) | 0.64A | 2y7jA-4b99A:26.6 | 2y7jA-4b99A:25.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Y7J_B_B49B1294_1 (PHOSPHORYLASE BKINASE GAMMACATALYTIC CHAIN,TESTIS/LIVER ISOFORM) |
4b99 | MITOGEN-ACTIVATEDPROTEIN KINASE 7 (Homosapiens) | 7 / 10 | ILE A 61VAL A 69ALA A 82ILE A 115LEU A 139MET A 140LEU A 189 | R4L A1394 (-4.0A)R4L A1394 (-4.0A)R4L A1394 ( 3.7A)R4L A1394 (-4.9A)R4L A1394 ( 4.9A)NoneR4L A1394 (-4.5A) | 0.68A | 2y7jB-4b99A:26.7 | 2y7jB-4b99A:25.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Y7J_C_B49C1294_1 (PHOSPHORYLASE BKINASE GAMMACATALYTIC CHAIN,TESTIS/LIVER ISOFORM) |
4b99 | MITOGEN-ACTIVATEDPROTEIN KINASE 7 (Homosapiens) | 7 / 10 | ILE A 61VAL A 69ALA A 82ILE A 115LEU A 139MET A 140LEU A 189 | R4L A1394 (-4.0A)R4L A1394 (-4.0A)R4L A1394 ( 3.7A)R4L A1394 (-4.9A)R4L A1394 ( 4.9A)NoneR4L A1394 (-4.5A) | 0.67A | 2y7jC-4b99A:26.7 | 2y7jC-4b99A:25.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Y7J_D_B49D1294_1 (PHOSPHORYLASE BKINASE GAMMACATALYTIC CHAIN,TESTIS/LIVER ISOFORM) |
4b99 | MITOGEN-ACTIVATEDPROTEIN KINASE 7 (Homosapiens) | 7 / 10 | ILE A 61VAL A 69ALA A 82ILE A 115LEU A 139MET A 140LEU A 189 | R4L A1394 (-4.0A)R4L A1394 (-4.0A)R4L A1394 ( 3.7A)R4L A1394 (-4.9A)R4L A1394 ( 4.9A)NoneR4L A1394 (-4.5A) | 0.69A | 2y7jD-4b99A:26.7 | 2y7jD-4b99A:25.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GP0_A_NILA1_1 (MITOGEN-ACTIVATEDPROTEIN KINASE 11) |
4b99 | MITOGEN-ACTIVATEDPROTEIN KINASE 7 (Homosapiens) | 6 / 12 | VAL A 69ALA A 82LEU A 106ILE A 115HIS A 180ASP A 200 | R4L A1394 (-4.0A)R4L A1394 ( 3.7A)NoneR4L A1394 (-4.9A)NoneNone | 1.00A | 3gp0A-4b99A:37.6 | 3gp0A-4b99A:43.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GP0_A_NILA1_2 (MITOGEN-ACTIVATEDPROTEIN KINASE 11) |
4b99 | MITOGEN-ACTIVATEDPROTEIN KINASE 7 (Homosapiens) | 4 / 7 | LYS A 84LEU A 139MET A 140ILE A 198 | NoneR4L A1394 ( 4.9A)NoneNone | 0.87A | 3gp0A-4b99A:37.6 | 3gp0A-4b99A:43.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HEC_A_STIA1_1 (MITOGEN-ACTIVATEDPROTEIN KINASE 14) |
4b99 | MITOGEN-ACTIVATEDPROTEIN KINASE 7 (Homosapiens) | 5 / 12 | ALA A 82GLU A 102LEU A 106ILE A 115LEU A 139 | R4L A1394 ( 3.7A)NoneNoneR4L A1394 (-4.9A)R4L A1394 ( 4.9A) | 0.88A | 3hecA-4b99A:35.9 | 3hecA-4b99A:41.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HEC_A_STIA1_1 (MITOGEN-ACTIVATEDPROTEIN KINASE 14) |
4b99 | MITOGEN-ACTIVATEDPROTEIN KINASE 7 (Homosapiens) | 5 / 12 | ALA A 82LEU A 106ILE A 115LEU A 139ASP A 200 | R4L A1394 ( 3.7A)NoneR4L A1394 (-4.9A)R4L A1394 ( 4.9A)None | 0.73A | 3hecA-4b99A:35.9 | 3hecA-4b99A:41.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HEC_A_STIA1_1 (MITOGEN-ACTIVATEDPROTEIN KINASE 14) |
4b99 | MITOGEN-ACTIVATEDPROTEIN KINASE 7 (Homosapiens) | 5 / 12 | ALA A 82LYS A 84ILE A 115LEU A 139ASP A 200 | R4L A1394 ( 3.7A)NoneR4L A1394 (-4.9A)R4L A1394 ( 4.9A)None | 0.63A | 3hecA-4b99A:35.9 | 3hecA-4b99A:41.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HEG_A_BAXA1_1 (MITOGEN-ACTIVATEDPROTEIN KINASE 14) |
4b99 | MITOGEN-ACTIVATEDPROTEIN KINASE 7 (Homosapiens) | 6 / 12 | VAL A 69ALA A 82LYS A 84GLU A 102LEU A 106ILE A 115 | R4L A1394 (-4.0A)R4L A1394 ( 3.7A)NoneNoneNoneR4L A1394 (-4.9A) | 0.85A | 3hegA-4b99A:36.5 | 3hegA-4b99A:41.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OZU_A_X89A411_1 (FLAVOHEMOPROTEIN) |
4b99 | MITOGEN-ACTIVATEDPROTEIN KINASE 7 (Homosapiens) | 5 / 12 | ILE A 115ALA A 82LEU A 137VAL A 135ALA A 89 | R4L A1394 (-4.9A)R4L A1394 ( 3.7A)R4L A1394 (-3.9A)NoneNone | 1.04A | 3ozuA-4b99A:undetectable | 3ozuA-4b99A:22.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3V5W_A_8PRA701_1 (G-PROTEIN COUPLEDRECEPTOR KINASE 2) |
4b99 | MITOGEN-ACTIVATEDPROTEIN KINASE 7 (Homosapiens) | 6 / 12 | GLY A 64GLY A 67VAL A 69ALA A 82LYS A 84LEU A 189 | NoneNoneR4L A1394 (-4.0A)R4L A1394 ( 3.7A)NoneR4L A1394 (-4.5A) | 0.85A | 3v5wA-4b99A:25.7 | 3v5wA-4b99A:21.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3V5W_A_8PRA701_2 (G-PROTEIN COUPLEDRECEPTOR KINASE 2) |
4b99 | MITOGEN-ACTIVATEDPROTEIN KINASE 7 (Homosapiens) | 3 / 3 | LEU A 137MET A 140ASP A 143 | R4L A1394 (-3.9A)NoneR4L A1394 ( 4.2A) | 0.57A | 3v5wA-4b99A:25.7 | 3v5wA-4b99A:21.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ZBF_A_VGHA3000_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE ROS) |
4b99 | MITOGEN-ACTIVATEDPROTEIN KINASE 7 (Homosapiens) | 7 / 12 | ALA A 82LEU A 137LEU A 139MET A 140ASP A 143LEU A 189GLY A 199 | R4L A1394 ( 3.7A)R4L A1394 (-3.9A)R4L A1394 ( 4.9A)NoneR4L A1394 ( 4.2A)R4L A1394 (-4.5A)R4L A1394 ( 4.1A) | 0.74A | 3zbfA-4b99A:23.2 | 3zbfA-4b99A:24.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ZBF_A_VGHA3000_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE ROS) |
4b99 | MITOGEN-ACTIVATEDPROTEIN KINASE 7 (Homosapiens) | 7 / 12 | LEU A 137LEU A 139MET A 140ASP A 143LEU A 189GLY A 199ASP A 200 | R4L A1394 (-3.9A)R4L A1394 ( 4.9A)NoneR4L A1394 ( 4.2A)R4L A1394 (-4.5A)R4L A1394 ( 4.1A)None | 0.73A | 3zbfA-4b99A:23.2 | 3zbfA-4b99A:24.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ZOS_A_0LIA1000_2 (EPITHELIAL DISCOIDINDOMAIN-CONTAININGRECEPTOR 1) |
4b99 | MITOGEN-ACTIVATEDPROTEIN KINASE 7 (Homosapiens) | 5 / 9 | ILE A 105ILE A 114ILE A 115MET A 140ILE A 198 | NoneNoneR4L A1394 (-4.9A)NoneNone | 0.92A | 3zosA-4b99A:6.7 | 3zosA-4b99A:26.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4C8B_A_0LIA1000_2 (RECEPTOR-INTERACTINGSERINE/THREONINE-PROTEIN KINASE 2) |
4b99 | MITOGEN-ACTIVATEDPROTEIN KINASE 7 (Homosapiens) | 4 / 5 | VAL A 69ILE A 114MET A 140ILE A 198 | R4L A1394 (-4.0A)NoneNoneNone | 0.55A | 4c8bA-4b99A:22.1 | 4c8bA-4b99A:24.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4C8B_B_0LIB1000_1 (RECEPTOR-INTERACTINGSERINE/THREONINE-PROTEIN KINASE 2) |
4b99 | MITOGEN-ACTIVATEDPROTEIN KINASE 7 (Homosapiens) | 7 / 12 | ALA A 82LYS A 84LEU A 106ILE A 114HIS A 180LEU A 189ASP A 200 | R4L A1394 ( 3.7A)NoneNoneNoneNoneR4L A1394 (-4.5A)None | 0.88A | 4c8bB-4b99A:22.3 | 4c8bB-4b99A:24.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4IAA_A_RTZA401_1 (SERINE/THREONINE-PROTEIN KINASE PIM-1) |
4b99 | MITOGEN-ACTIVATEDPROTEIN KINASE 7 (Homosapiens) | 6 / 11 | VAL A 69ALA A 82LYS A 84LEU A 137ASP A 143LEU A 189 | R4L A1394 (-4.0A)R4L A1394 ( 3.7A)NoneR4L A1394 (-3.9A)R4L A1394 ( 4.2A)R4L A1394 (-4.5A) | 0.58A | 4iaaA-4b99A:22.5 | 4iaaA-4b99A:24.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MKC_A_4MKA1503_1 (ALK TYROSINE KINASERECEPTOR) |
4b99 | MITOGEN-ACTIVATEDPROTEIN KINASE 7 (Homosapiens) | 8 / 12 | GLY A 64VAL A 69ALA A 82LYS A 84LEU A 137LEU A 139ASP A 143LEU A 189 | NoneR4L A1394 (-4.0A)R4L A1394 ( 3.7A)NoneR4L A1394 (-3.9A)R4L A1394 ( 4.9A)R4L A1394 ( 4.2A)R4L A1394 (-4.5A) | 0.73A | 4mkcA-4b99A:22.7 | 4mkcA-4b99A:24.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MKC_A_4MKA1503_1 (ALK TYROSINE KINASERECEPTOR) |
4b99 | MITOGEN-ACTIVATEDPROTEIN KINASE 7 (Homosapiens) | 8 / 12 | GLY A 64VAL A 69LYS A 84LEU A 137LEU A 139ASP A 143LEU A 189ASP A 200 | NoneR4L A1394 (-4.0A)NoneR4L A1394 (-3.9A)R4L A1394 ( 4.9A)R4L A1394 ( 4.2A)R4L A1394 (-4.5A)None | 0.74A | 4mkcA-4b99A:22.7 | 4mkcA-4b99A:24.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4R7I_A_STIA1001_1 (MACROPHAGECOLONY-STIMULATINGFACTOR 1 RECEPTOR) |
4b99 | MITOGEN-ACTIVATEDPROTEIN KINASE 7 (Homosapiens) | 6 / 12 | VAL A 69ALA A 82LYS A 84LEU A 189GLY A 199ASP A 200 | R4L A1394 (-4.0A)R4L A1394 ( 3.7A)NoneR4L A1394 (-4.5A)R4L A1394 ( 4.1A)None | 0.70A | 4r7iA-4b99A:20.9 | 4r7iA-4b99A:22.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4RZ7_A_1E8A901_1 (CGMP-DEPENDENTPROTEIN KINASE,PUTATIVE) |
4b99 | MITOGEN-ACTIVATEDPROTEIN KINASE 7 (Homosapiens) | 5 / 10 | ILE A 61ALA A 82LYS A 84ILE A 115LEU A 139 | R4L A1394 (-4.0A)R4L A1394 ( 3.7A)NoneR4L A1394 (-4.9A)R4L A1394 ( 4.9A) | 0.69A | 4rz7A-4b99A:7.6 | 4rz7A-4b99A:18.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4RZ7_A_1E8A901_1 (CGMP-DEPENDENTPROTEIN KINASE,PUTATIVE) |
4b99 | MITOGEN-ACTIVATEDPROTEIN KINASE 7 (Homosapiens) | 5 / 10 | ILE A 61ALA A 82LYS A 84LEU A 139LEU A 189 | R4L A1394 (-4.0A)R4L A1394 ( 3.7A)NoneR4L A1394 ( 4.9A)R4L A1394 (-4.5A) | 0.57A | 4rz7A-4b99A:7.6 | 4rz7A-4b99A:18.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4V01_B_0LIB1770_2 (FIBROBLAST GROWTHFACTOR RECEPTOR 1(FMS-RELATEDTYROSINE KINASE 2,PFEIFFER SYNDROME),ISOFORM CRA_B) |
4b99 | MITOGEN-ACTIVATEDPROTEIN KINASE 7 (Homosapiens) | 6 / 9 | VAL A 69LYS A 84ILE A 105ILE A 115LEU A 189ILE A 198 | R4L A1394 (-4.0A)NoneNoneR4L A1394 (-4.9A)R4L A1394 (-4.5A)None | 1.10A | 4v01B-4b99A:21.9 | 4v01B-4b99A:25.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XOY_A_DX4A401_0 (MITOGEN-ACTIVATEDPROTEIN KINASE 1) |
4b99 | MITOGEN-ACTIVATEDPROTEIN KINASE 7 (Homosapiens) | 4 / 6 | ALA A 82LEU A 139MET A 140LEU A 189 | R4L A1394 ( 3.7A)R4L A1394 ( 4.9A)NoneR4L A1394 (-4.5A) | 0.46A | 4xoyA-4b99A:16.0 | 4xoyA-4b99A:46.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XP3_A_DX4A401_0 (MITOGEN-ACTIVATEDPROTEIN KINASE 1) |
4b99 | MITOGEN-ACTIVATEDPROTEIN KINASE 7 (Homosapiens) | 4 / 6 | ALA A 82LEU A 139MET A 140LEU A 189 | R4L A1394 ( 3.7A)R4L A1394 ( 4.9A)NoneR4L A1394 (-4.5A) | 0.54A | 4xp3A-4b99A:38.7 | 4xp3A-4b99A:46.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5AAA_A_VGHA9000_1 (ALK TYROSINE KINASERECEPTOR) |
4b99 | MITOGEN-ACTIVATEDPROTEIN KINASE 7 (Homosapiens) | 7 / 9 | VAL A 69ALA A 82LEU A 137MET A 140LEU A 189GLY A 199ASP A 200 | R4L A1394 (-4.0A)R4L A1394 ( 3.7A)R4L A1394 (-3.9A)NoneR4L A1394 (-4.5A)R4L A1394 ( 4.1A)None | 0.82A | 5aaaA-4b99A:22.6 | 5aaaA-4b99A:23.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5AAB_A_VGHA9000_1 (ALK TYROSINE KINASERECEPTOR) |
4b99 | MITOGEN-ACTIVATEDPROTEIN KINASE 7 (Homosapiens) | 8 / 10 | VAL A 69ALA A 82LYS A 84LEU A 137MET A 140LEU A 189GLY A 199ASP A 200 | R4L A1394 (-4.0A)R4L A1394 ( 3.7A)NoneR4L A1394 (-3.9A)NoneR4L A1394 (-4.5A)R4L A1394 ( 4.1A)None | 0.95A | 5aabA-4b99A:22.2 | 5aabA-4b99A:23.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5AAC_A_VGHA9000_1 (ALK TYROSINE KINASERECEPTOR) |
4b99 | MITOGEN-ACTIVATEDPROTEIN KINASE 7 (Homosapiens) | 8 / 10 | VAL A 69ALA A 82LYS A 84LEU A 137MET A 140LEU A 189GLY A 199ASP A 200 | R4L A1394 (-4.0A)R4L A1394 ( 3.7A)NoneR4L A1394 (-3.9A)NoneR4L A1394 (-4.5A)R4L A1394 ( 4.1A)None | 0.93A | 5aacA-4b99A:22.1 | 5aacA-4b99A:23.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5LW1_B_ADNB401_1 (MITOGEN-ACTIVATEDPROTEIN KINASE 8) |
4b99 | MITOGEN-ACTIVATEDPROTEIN KINASE 7 (Homosapiens) | 6 / 9 | ILE A 61GLY A 62VAL A 69ALA A 82ILE A 115MET A 140 | R4L A1394 (-4.0A)R4L A1394 (-3.6A)R4L A1394 (-4.0A)R4L A1394 ( 3.7A)R4L A1394 (-4.9A)None | 0.81A | 5lw1B-4b99A:35.7 | 5lw1B-4b99A:11.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5LW1_E_ADNE401_1 (MITOGEN-ACTIVATEDPROTEIN KINASE 8) |
4b99 | MITOGEN-ACTIVATEDPROTEIN KINASE 7 (Homosapiens) | 6 / 10 | GLY A 62VAL A 69ALA A 82ILE A 115LEU A 139MET A 140 | R4L A1394 (-3.6A)R4L A1394 (-4.0A)R4L A1394 ( 3.7A)R4L A1394 (-4.9A)R4L A1394 ( 4.9A)None | 0.55A | 5lw1E-4b99A:26.9 | 5lw1E-4b99A:11.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5LW1_H_ADNH401_1 (MITOGEN-ACTIVATEDPROTEIN KINASE 8) |
4b99 | MITOGEN-ACTIVATEDPROTEIN KINASE 7 (Homosapiens) | 5 / 9 | GLY A 62VAL A 69ALA A 82LEU A 139MET A 140 | R4L A1394 (-3.6A)R4L A1394 (-4.0A)R4L A1394 ( 3.7A)R4L A1394 ( 4.9A)None | 0.42A | 5lw1H-4b99A:35.9 | 5lw1H-4b99A:11.34 |